Pharma publication celebrates 'new blockbuster heart disease market'


https://www.fiercepharma.com/marketi...myopathy-cases

Pfizer, Alnylam and BMS take note: The US is poised to see 'a staggering number' of cardiomyopathy cases this decade

By Ben Adams
Jul 8, 2022 10:00am



_____________________________

Pharma publication celebrates 'new blockbuster heart disease market'

by: WorldTribune.com 07/13/2022 Source: WorldTribune.com